Home / Business & Finance / Taconic Biosciences unveils immuno-oncology mouse model

Taconic Biosciences unveils immuno-oncology mouse model

KUALA LUMPUR, Taconic Biosciences, a global leader in providing drug discovery animal model solutions has launched a new B2m-NOG mouse model, expanding its premier immuno-oncology portfolio.

The portfolio is built on the CIEA NOG mouse�, a severely immunodeficient mouse with diverse applications based on its improved ability to engraft human cells and tissues.

According to a statement, B2m-NOG significantly extends the study window after human peripheral blood mononuclear (PBMC) cell engraftment, providing more time to assess reactions to target drugs.

The extended study window dramatically expands immuno-oncology study types that can be run using the B2m-NOG model compared with more expensive and time-consuming options, such as hematopoietic stem cell-engrafted models.

Taconic also offers B2m-NOG mice pre-engrafted with human PBMCs.

Immuno-oncology leverages the body’s immune system to fight cancer, increasing the ability to target the disease.

Animal models used in this therapeutic development include special mice, which model human immune system function.

Source: BERNAMA (News Agency)

Check Also

Adhere to EC 3-MCPD rule to avoid another trade barrier – MPOB

KUALA LUMPUR, The whole palm oil supply chain needs to work together in meeting the European Commission (EC) proposed regulation of 2.5 ppm for 3-MCPD esters or the industry may face another trade barrier with the trading bloc, according to the Malaysi...